Active Ingredient: CILASTATIN SODIUM; IMIPENEM; RELEBACTAM
Proprietary Name: RECARBRIO
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 500MG BASE/VIAL;500MG/VIAL;250MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N212819
Product Number: 001
Approval Date: Jul 16, 2019
Applicant Holder Full Name: MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC
Marketing Status:
Prescription
Patent and Exclusivity Information